Related Experiment Video
Updated: Jun 30, 2025

10:33
Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
11.1K
Distinct molecular profiles drive multifaceted characteristics of colorectal cancer metastatic seeds
Yuanyuan Zhao1,2, Bing Zhang3,4, Yiming Ma5
1School of Pharmaceutical Sciences, Tsinghua University , Beijing, China.
The Journal of Experimental Medicine
|March 19, 2024
Summary
Metastasis in colorectal cancer (CRC) is driven by intrinsic factors within clones, not drug resistance. Identifying these "metastatic seeds" can improve diagnosis and target therapies.
Area of Science:
- Oncology
- Cancer Biology
- Genetics
Background:
- Metastasis of primary tumors is a significant challenge in cancer treatment and early diagnosis.
- The cellular and molecular characteristics of metastatic clones within primary tumors are not well understood.
Purpose of the Study:
- To identify and characterize metastatic seeds within colorectal cancer (CRC) tumors.
- To understand the intrinsic factors and molecular drivers that confer metastatic potential.
- To develop a gene signature for predicting metastatic potential in primary CRC.
Main Methods:
- Generation of single cell-derived lines from three primary CRC tumors.
- Characterization of metastatic potential and cellular communication capabilities of derived clones.
- Analysis of genetic alterations and mutation burden in relation to metastatic potential.
- Development and validation of a gene signature for metastatic potential.
Main Results:
- Intrinsic cellular factors, not drug resistance, determine metastatic potential and organ-specific metastasis.
- Poorly differentiated or highly metastatic clones, rather than drug-resistant ones, correlate with poor clinical prognosis.
- Personalized genetic alterations, not overall mutation burden, drive the emergence of metastatic potential during clonal evolution.
- A gene signature was developed to capture the metastatic potential of primary CRC tumors.
Conclusions:
- Metastatic potential in CRC originates from intrinsic properties of specific clones within the primary tumor.
- Understanding these metastatic drivers can lead to improved diagnostic tools and anti-metastatic therapeutic strategies.
- This research provides critical insights into the mechanisms of metastasis for CRC patients.
Related Concept Videos
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K

